These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
559 related items for PubMed ID: 26252472
1. Propensity Score Matching Analysis of Changes in Alpha-Fetoprotein Levels after Combined Radiotherapy and Transarterial Chemoembolization for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. Jeong Y, Yoon SM, Han S, Shim JH, Kim KM, Lim YS, Lee HC, Kim SY, Park JH, Lee SW, Ahn SD, Choi EK, Kim JH. PLoS One; 2015; 10(8):e0135298. PubMed ID: 26252472 [Abstract] [Full Text] [Related]
2. Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes. Yoon SM, Lim YS, Won HJ, Kim JH, Kim KM, Lee HC, Chung YH, Lee YS, Lee SG, Park JH, Suh DJ. Int J Radiat Oncol Biol Phys; 2012 Apr 01; 82(5):2004-11. PubMed ID: 21621346 [Abstract] [Full Text] [Related]
3. Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma. Lee JS, Chon YE, Kim BK, Park JY, Kim DY, Ahn SH, Han KH, Kang W, Choi MS, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Kim HY, Kim TH, Yoo K, Ha Y, Kim MN, Lee JH, Hwang SG, Kim SS, Cho HJ, Cheong JY, Cho SW, Park SH, Heo NY, Hong YM, Yoon KT, Cho M, Park JG, Kang MK, Park SY, Kweon YO, Tak WY, Jang SY, Sinn DH, Kim SU, Korean TACE Study Group. Yonsei Med J; 2021 Jan 01; 62(1):12-20. PubMed ID: 33381930 [Abstract] [Full Text] [Related]
4. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis. Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ. Biomed Res Int; 2021 Jan 01; 2021():6670367. PubMed ID: 34337041 [Abstract] [Full Text] [Related]
5. Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis. Lee JM, Jang BK, Lee YJ, Choi WY, Choi SM, Chung WJ, Hwang JS, Kang KJ, Kim YH, Chauhan AK, Park SY, Tak WY, Kweon YO, Kim BS, Lee CH. Clin Mol Hepatol; 2016 Mar 01; 22(1):160-7. PubMed ID: 27044767 [Abstract] [Full Text] [Related]
6. Combination of transarterial chemoembolization and three-dimensional conformal radiotherapy for hepatocellular carcinoma with inferior vena cava tumor thrombus. Koo JE, Kim JH, Lim YS, Park SJ, Won HJ, Sung KB, Suh DJ. Int J Radiat Oncol Biol Phys; 2010 Sep 01; 78(1):180-7. PubMed ID: 19926229 [Abstract] [Full Text] [Related]
7. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis. Yamamoto Y, Ikoma H, Morimura R, Shoda K, Konishi H, Murayama Y, Komatsu S, Shiozaki A, Kuriu Y, Kubota T, Nakanishi M, Ichikawa D, Fujiwara H, Okamoto K, Sakakura C, Ochiai T, Otsuji E. World J Gastroenterol; 2015 Jan 07; 21(1):246-53. PubMed ID: 25574098 [Abstract] [Full Text] [Related]
8. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M, Wang JP, Li W, Huang ZL, Zhang FJ, Fan WJ, Zhang L, Li XS, Pan CC, Wu PH. Zhonghua Yi Xue Za Zhi; 2011 May 10; 91(17):1167-72. PubMed ID: 21756768 [Abstract] [Full Text] [Related]
9. [Efficacy of 3-dimensional conformal hypofractionated single high-dose radiotherapy combined with transcatheter arterial chemoembolization for portal vein tumor thrombus in patients with hepatocellular carcinoma]. Wu DH, Chen LH. Ai Zheng; 2004 Jul 10; 23(7):825-8. PubMed ID: 15248921 [Abstract] [Full Text] [Related]
10. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B, Yu J, Wang L, Li C, Zhou T, Zhai L, Xing L. Am J Clin Oncol; 2003 Aug 10; 26(4):e92-9. PubMed ID: 12902905 [Abstract] [Full Text] [Related]
11. Prognostic significance of alpha-fetoprotein status in the outcome of hepatocellular carcinoma after treatment of transarterial chemoembolization. Wang Y, Chen Y, Ge N, Zhang L, Xie X, Zhang J, Chen R, Wang Y, Zhang B, Xia J, Gan Y, Ren Z, Ye S. Ann Surg Oncol; 2012 Oct 10; 19(11):3540-6. PubMed ID: 22532305 [Abstract] [Full Text] [Related]
12. [Comparison of therapeutics effects of transcatheter arterial chemoembolization combined with iodine-125 seed implantation and sorafenib for the treatment of hepatocellular carcinoma with portal vein tumor thrombosis]. Luo J, Zheng JP, Shao GL, Wen S, Guo LW, Zeng H, Zhang L, Qian CY, Hao WY. Zhonghua Gan Zang Bing Za Zhi; 2018 Apr 20; 26(4):298-304. PubMed ID: 29996343 [Abstract] [Full Text] [Related]
13. Apatinib Combined With Transarterial Chemoembolization in Patients With Hepatocellular Carcinoma and Portal Vein Tumor Thrombus: A Multicenter Retrospective Study. Fan W, Yuan G, Fan H, Li F, Wu Y, Zhao Y, Yao W, Wang Y, Xue M, Yang J, Li J. Clin Ther; 2019 Aug 20; 41(8):1463-1476. PubMed ID: 31303279 [Abstract] [Full Text] [Related]
14. Multimodality Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Large-Scale, Multicenter, Propensity Mathching Score Analysis. Wang K, Guo WX, Chen MS, Mao YL, Sun BC, Shi J, Zhang YJ, Meng Y, Yang YF, Cong WM, Wu MC, Lau WY, Cheng SQ. Medicine (Baltimore); 2016 Mar 20; 95(11):e3015. PubMed ID: 26986115 [Abstract] [Full Text] [Related]
15. Safety and efficacy of transarterial chemoembolization plus sorafenib for hepatocellular carcinoma with portal venous tumour thrombus. Pan T, Li XS, Xie QK, Wang JP, Li W, Wu PH, Zhao M. Clin Radiol; 2014 Dec 20; 69(12):e553-61. PubMed ID: 25304928 [Abstract] [Full Text] [Related]
16. Alpha-fetoprotein normalization as a prognostic surrogate in small hepatocellular carcinoma after stereotactic body radiotherapy: a propensity score matching analysis. Jung J, Yoon SM, Han S, Shim JH, Kim KM, Lim YS, Lee HC, Kim SY, Park JH, Kim JH. BMC Cancer; 2015 Dec 18; 15():987. PubMed ID: 26681337 [Abstract] [Full Text] [Related]
17. Prognostic value of α-fetoprotein and des-γ-carboxy prothrombin responses in patients with hepatocellular carcinoma treated with transarterial chemoembolization. Lee YK, Kim SU, Kim DY, Ahn SH, Lee KH, Lee DY, Han KH, Chon CY, Park JY. BMC Cancer; 2013 Jan 03; 13():5. PubMed ID: 23282286 [Abstract] [Full Text] [Related]
18. Combined endovascular brachytherapy, sorafenib, and transarterial chemobolization therapy for hepatocellular carcinoma patients with portal vein tumor thrombus. Zhang ZH, Liu QX, Zhang W, Ma JQ, Wang JH, Luo JJ, Liu LX, Yan ZP. World J Gastroenterol; 2017 Nov 21; 23(43):7735-7745. PubMed ID: 29209114 [Abstract] [Full Text] [Related]
19. Clinical impact of combined transarterial chemoembolization and radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: An external validation study. Yu JI, Park JW, Park HC, Yoon SM, Lim DH, Lee JH, Lee HC, Kim SW, Kim JH. Radiother Oncol; 2016 Feb 21; 118(2):408-15. PubMed ID: 26830695 [Abstract] [Full Text] [Related]
20. Early α-fetoprotein response as a predictor for clinical outcome after localized concurrent chemoradiotherapy for advanced hepatocellular carcinoma. Kim BK, Ahn SH, Seong JS, Park JY, Kim DY, Kim JK, Lee DY, Lee KH, Han KH. Liver Int; 2011 Mar 21; 31(3):369-76. PubMed ID: 21083802 [Abstract] [Full Text] [Related] Page: [Next] [New Search]